CLINICAL EVALUATION OF ASHWAGANDHADI COMPOUND IN THE MANAGEMENT OF PERIMENOPAUSAL SYMPTOMS

Abstract

Menopause is an important phase in every woman’s life.Perimenopause is menopause transition -al period around menopause (40 – 55years) presenting with psychological and somatic symptoms. Prevalence of psychological and somatic symptoms is seen in 80% of women at perimenopausal period. The present clinical trial was designed as per Ayurveda clinical trials protocol to evaluate the efficacy of Ashwagandhadi compound which contains Ashwagandha Shatavari and Brahmi in equal quantity,to evaluate the effect of placebo and Comparison of the effects of Ashvgandhadi compound with placebo group to ascertain its effect in the management of perimenopause symptoms. In the present clinical study, 40 patients of Perimenopausal symptoms were treated in two group, total 40 patients completed the study plan. Highly significant reduction value is found in the Ashwagandhadi group (p<.001). It can be stated that Ashwagandhadi group gives better result in both somatic and psychological complaints in women with mild to moderate symptoms of perimenopausal symptoms.